Literature DB >> 24871630

Renal nerves: time for reassessment of their role in hypertension?

Gregory D Fink1, John W Osborn2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24871630      PMCID： PMC4565653          DOI： 10.1093/ajh/hpu096

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  12 in total

Review 1.  Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation.

Authors:  Markus P Schlaich; Murray D Esler; Greg D Fink; John W Osborn; David E Euler
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

Review 2.  Renal sympathetic denervation for the treatment of refractory hypertension.

Authors:  Kui Toh Gerard Leong; Antony Walton; Henry Krum
Journal:  Annu Rev Med       Date:  2014       Impact factor: 13.739

Review 3.  The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction?

Authors:  M Esler; M Rumantir; D Kaye; G Lambert
Journal:  Am J Hypertens       Date:  2001-06       Impact factor: 2.689

Review 4.  The sympathetic system and hypertension.

Authors:  M Esler
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

Review 5.  Translational medicine: the antihypertensive effect of renal denervation.

Authors:  Gerald F DiBona; Murray Esler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-02       Impact factor: 3.619

6.  Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.

Authors:  Dominik Linz; Felix Mahfoud; Benedikt Linz; Mathias Hohl; Stephan H Schirmer; Klaus J Wirth; Michael Böhm
Journal:  Am J Hypertens       Date:  2014-03-12       Impact factor: 2.689

Review 7.  Obstructive sleep apnea and insight into mechanisms of sympathetic overactivity.

Authors:  François Abboud; Ravinder Kumar
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

8.  Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs.

Authors:  Jeffrey R Henegar; Yongxing Zhang; Rita De Rama; Cary Hata; Michael E Hall; John E Hall
Journal:  Am J Hypertens       Date:  2014-04-06       Impact factor: 2.689

9.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  2 in total

1.  Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension.

Authors:  Melvin D Lobo; Mark A de Belder; Trevor Cleveland; David Collier; Indranil Dasgupta; John Deanfield; Vikas Kapil; Charles Knight; Matthew Matson; Jonathan Moss; Julian F R Paton; Neil Poulter; Iain Simpson; Bryan Williams; Mark J Caulfield
Journal:  Heart       Date:  2014-11-27       Impact factor: 5.994

Review 2.  Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review).

Authors:  Xianliang Dai; Li Hua; Yihong Chen; Jiamei Wang; Jingyi Li; Feng Wu; Yanda Zhang; Jiyuan Su; Zonggui Wu; Chun Liang
Journal:  Int J Mol Med       Date:  2018-03-30       Impact factor: 4.101
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.